In contrast, PD-L2, as the secondary ligand for PD-1, is more confined in antigen-presenting cells (APCs, for example, macrophages and dendritic cells) stimulated by cytokines, and can also be induced in other immune cells, non-immune cells, and tumor cells 15. The gene discussed is SNCA; the disease is neoplasm.